Behaviour and hormonal status in healthy rats on a diet rich in Maillard reaction products with or without solvent extractable aroma compounds

Physiology and Behavior

Volumn 105, Issue 3, 2012, Pages 693-701

  Šebeková, Katarína ^a   Klenovics, Kristína Simon ^a,b   Boor, Peter ^a,c   Celec, Peter ^a   Behuliak, Michal ^a   Schieberle, Peter ^d   Heidland, August ^e   Palkovits, Miklós ^f   Somoza, Veronika ^d,g  

^a Physics and Informatics   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d DEUTSCHE FORSCHUNGSANSTALT FÜR LEBENSMITTELCHEMIE   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f SEMMELWEIS UNIVERSITY   (Hungary)

^g UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adipokines; Behavioural phenotyping; Fos immunohistochemistry; Insulin resistance; Maillard reaction products; Solvent extractable aroma compounds

Indexed keywords

ADIPOCYTOKINE; ANOREXIGENIC AGENT; FLAVORING AGENT; INSULIN RECEPTOR; LEPTIN RECEPTOR;

ARTICLE; BEHAVIOR; BLOOD GLUCOSE MONITORING; BREAD; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FOOD INTAKE; FOOD PROCESSING; GLYCATION; HOMEOSTASIS; HORMONE RESPONSE; HYPERLEPTINEMIA; HYPOTHALAMUS; IN VIVO STUDY; MALE; NERVE CONDUCTION; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOLVENT EXTRACTION;

ADIPONECTIN; ANIMAL FEED; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; DARK ADAPTATION; DIET; EATING; ENERGY METABOLISM; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; HORMONES; HYPOTHALAMUS; LYSINE; MAILLARD REACTION; MALE; OLFACTORY BULB; ONCOGENE PROTEINS V-FOS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; RECEPTORS, LEPTIN;

EID: 80155214089     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.10.004     Document Type: Article

References (52)

1. Breer H. The sense of smell: reception of flavors. Ann N Y Acad Sci 2008, 1126:1-6.
2. Shepherd G.M. The human sense of smell: are we better than we think?. PLoS Biol 2004, 2:E146.
3. Sucan M.K., Weerasinghe D.K. Process and reaction flavours. An Overview. Process and reaction flavours 2005, 1-23. ACS Symposium Series, Washington. D.K. Weerasinghe, M.K. Sucan (Eds.).
4. Kirchhoff E., Schieberle P. Determination of key aroma compounds in the crumb of a three-stage sourdough rye bread by stable isotope dilution assays and sensory studies. J Agric Food Chem 2001, 49:4304-4311.
5. Schieberle P., Grosch W. Potent odorants of rye bread crust - differences from the crumb and from wheat bread crust. Z Lebensm Unters Forsch 1994, 198:292-296.
6. Schifferl P. Bread aroma, production thereof, and use of the same for the aromatisation of foodstuffs and delicacies EP0413368. European Patent 1994.
7. Faturi C.B., Leite J.R., Alves P.B., Canton A.C., Teixeira-Silva F. Anxiolytic-like effect of sweet orange aroma in Wistar rats. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:605-609.
8. Yeomans M.R. Olfactory influences on appetite and satiety in humans. Physiol Behav 2006, 89:10-14.
9. Ruijschop R.M., Boelrijk A.E., Burgering M.J., de Graaf C., Westerterp-Plantenga M.S. Acute effects of complexity in aroma composition on satiation and food intake. Chem Senses 2010, 35:91-100.
10. Kushner L.R., Mook D.G. Behavioral correlates of oral and postingestive satiety in the rat. Physiol Behav 1984, 33:713-718.
11. Kubow S., Anderson G.H., Blendis L.M., Goldberg E. 3-methylbutanal metabolism in the adult rat. Clin Sci (Lond) 1981, 61:451-455.
12. Jung H.J., Fahey G.C. Effects of phenolic monomers on rat performance and metabolism. J Nutr 1983, 113:546-556.
13. Sebekova K., Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects-PRO. Mol Nutr Food Res 2007, 51:1079-1084.
14. Birlouez-Aragon I., Saavedra G., Tessier F.J., Galinier A., Ait-Ameur L., Lacoste F., et al. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 2010, 91:1220-1226.
15. Cassese A., Esposito I., Fiory F., Barbagallo A.P., Paturzo F., Mirra P., et al. In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J Biol Chem 2008, 283:36088-36099.
16. Unoki H., Bujo H., Yamagishi S., Takeuchi M., Imaizumi T., Saito Y. Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 2007, 76:236-244.
17. Puddu A., Storace D., Odetti P., Viviani G.L. Advanced glycation end-products affect transcription factors regulating insulin gene expression. Biochem Biophys Res Commun 2010, 395:122-125.
18. Uribarri J., Cai W., Peppa M., Goodman S., Ferrucci L., Striker G., et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 2007, 62:427-433.
19. Tahara N., Yamagishi S.I., Matsui T., Takeuchi M., Nitta Y., Kodama N., et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc Ther 2010.
20. Tan K.C., Shiu S.W., Wong Y., Tam X. Serum advanced glycation end products (AGEs) are associated with insulin resistance. Diabetes Metab Res Rev 2011, 27:488-492.
21. Tessier F.J., Birlouez-Aragon I. Health effects of dietary Maillard reaction products: the results of ICARE and other studies. Amino Acids 2010.
22. Kagami K., Onda K., Oka K., Hirano T. Suppression of blood lipid concentrations by volatile Maillard reaction products. Nutrition 2008, 24:1159-1166.
23. Lindenmeier M., Faist V., Hofmann T. Structural and functional characterization of pronyl-lysine, a novel protein modification in bread crust melanoidins showing in vitro antioxidative and phase I/II enzyme modulating activity. J Agric Food Chem 2002, 50:6997-7006.
24. Muniyappa R., Chen H., Muzumdar R., Einstein F.H., Yan X., Yue L.Q., et al. Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats. Am J Physiol Endocrinol Metab 2009.
25. Witko-Sarsat V., Friedlander M., Nguyen Khoa T., Capeillere-Blandin C., Nguyen A.T., Canteloup S., et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998, 161:2524-2532.
26. Munch G., Keis R., Wessels A., Riederer P., Bahner U., Heidland A., et al. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997, 35:669-677.
27. Palkovits M., Sebekova K., Gallatz K., Boor P., Sebekova K., Klassen A., et al. Neuronal activation in the CNS during different forms of acute renal failure in rats. Neuroscience 2009, 159:862-882.
28. Ramos A. Animal models of anxiety: do I need multiple tests?. Trends Pharmacol Sci 2008, 29:493-498.
29. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
30. Ambrogi Lorenzini C., Bucherelli C., Giachetti A. Passive and active avoidance behavior in the light-dark box test. Physiol Behav 1984, 32:687-689.
31. Sebekova K., Saavedra G., Zumpe C., Somoza V., Klenovicsova K., Birlouez-Aragon I. Plasma concentration and urinary excretion of N epsilon-(carboxymethyl)lysine in breast milk- and formula-fed infants. Ann N Y Acad Sci 2008, 1126:177-180.
32. Stirban A., Negrean M., Gotting C., Uribarri J., Gawlowski T., Stratmann B., et al. Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann N Y Acad Sci 2008, 1126:276-279.
33. Uribarri J., Cai W., Ramdas M., Goodman S., Pyzik R., Chen X., et al. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 2011, 34:1610-1616.
34. Banks W.A. The source of cerebral insulin. Eur J Pharmacol 2004, 490:5-12.
35. Weinberg M.S., Girotti M., Spencer R.L. Restraint-induced fra-2 and c-fos expression in the rat forebrain: relationship to stress duration. Neuroscience 2007, 150:478-486.
36. Birlouez-Aragon I., Pischetsrieder M., Leclere J., Morales F.J., Hasenkopf K., Kientsch-Engel R., et al. Assessment of protein glycation markers in infant formulas. Food Chem 2004, 87:253-259.
37. Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148:293-300.
38. Baculíková M., Gajdošechová L., Fiala R., Grančič P., Kebis A., Kukan M., et al. Reduced angiotensin II mediated protein oxidation in adipose tissue of 12-week-old Zucker rats. Collection Symposium Series 2009, 4-8. Academy of Sciences, Praha Czech Republic. V. Čeřovský, J. Slaninová, T. Zórad, M. Flegel (Eds.).
39. Pan W., Kastin A.J. Adipokines and the blood-brain barrier. Peptides 2007, 28:1317-1330.
40. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
41. Niswender K.D., Schwartz M.W. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol 2003, 24:1-10.
42. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
43. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48:1-9.
44. Lacroix M.C., Badonnel K., Meunier N., Tan F., Schlegel-Le Poupon C., Durieux D., et al. Expression of insulin system in the olfactory epithelium: first approaches to its role and regulation. J Neuroendocrinol 2008, 20:1176-1190.
45. Savigner A., Duchamp-Viret P., Grosmaitre X., Chaput M., Garcia S., Ma M., et al. Modulation of spontaneous and odorant-evoked activity of rat olfactory sensory neurons by two anorectic peptides, insulin and leptin. J Neurophysiol 2009, 101:2898-2906.
46. Boor P., Celec P., Behuliak M., Grancic P., Kebis A., Kukan M., et al. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Metab Clin Exp 2009, 58:1669-1677.
47. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006, 8:264-280.
48. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295.
49. Yoon M.J., Lee G.Y., Chung J.J., Ahn Y.H., Hong S.H., Kim J.B. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 2006, 55:2562-2570.
50. Keeler C. The association of the black (non-agouti) gene with behavior in the Norway rat. J Hered 1942, 33:371-384.
51. Sachs B.D. Penile erection in response to remote cues from females: albino rats severely impaired relative to pigmented strains. Physiol Behav 1996, 60:803-808.
52. Arnold M., Langhans W. Effects of anesthesia and blood sampling techniques on plasma metabolites and corticosterone in the rat. Physiol Behav 2010, 99:592-598.